Clinical Trials Browser

Phase 2 × Immunoglobulin Light-chain Amyloidosis × Specimen Handling × Clear all

NCT05898646 2026-01-13

Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial

Phase 2 Recruiting

Immunoglobulin Light-chain Amyloidosis